Bandwidth utilization in a PPRC system
    1.
    发明授权
    Bandwidth utilization in a PPRC system 失效
    PPRC系统中的带宽利用率

    公开(公告)号:US07065623B2

    公开(公告)日:2006-06-20

    申请号:US10719536

    申请日:2003-11-20

    IPC分类号: G06F12/00

    摘要: Methods, system and computer program product are provided to improve the efficiency of data transfers in a PPRC environment. A block of data to be transferred is divided into tracks. Each track is allocated to a data mover task control block (TCB) with a master TCB being assigned to supervise the data mover TCBs. The tracks are then transferred from the primary storage controller to the secondary controller in a piped fashion over a link coupling the primary and secondary storage controllers. However, the usage of resources is monitored by a resource management algorithm and, if too many TCBs are being used for a transfer or if the supply of data mover TCBs is exhausted, the transfer is automatically switched to a serial, non-piped transfer with the master TCB serving as the data mover TCB for the remaining tracks. In addition, the various links coupling the primary and secondary storage controllers is monitored to determine which link will provide the fastest transfer. If, during a transfer of tracks over one link, a faster link is identified, the transfer may be switched to the second, faster link.

    摘要翻译: 提供了方法,系统和计算机程序产品,以提高PPRC环境中数据传输的效率。 要传输的数据块被划分为轨道。 每个轨道被分配给数据移动器任务控制块(TCB),其中主TCB被分配以监视数据移动器TCB。 然后,通过连接主存储控制器和辅助存储控制器的链路,将轨道以管道方式从主存储控制器传送到次级控制器。 然而,资源的使用通过资源管理算法进行监控,如果太多的TCB被用于传输,或者如果数据移动器TCB的供应耗尽,则传输将自动切换到串行,非管道传输, 主TCB用作剩余磁道的数据移动器TCB。 此外,监视耦合主存储控制器和辅助存储控制器的各种链路,以确定哪个链路将提供最快的传输。 如果在通过一个链路传送轨道的过程中识别出更快的链路,则可以将传输切换到第二个更快的链路。

    Autonomic infrastructure enablement for point in time copy consistency
    2.
    发明授权
    Autonomic infrastructure enablement for point in time copy consistency 失效
    自动基础设施启用时间点复制一致性

    公开(公告)号:US07610318B2

    公开(公告)日:2009-10-27

    申请号:US10674900

    申请日:2003-09-29

    IPC分类号: G06F17/30

    摘要: A two-phase process FlashCopy operation is provided that can be used to aid in the formation of consistency groups across multiple storage control units. In the first phase, preparations to create a new consistency group are made “revertible” by write-inhibiting the source volumes through “Establish-FlashCopy-revertible” commands. If the preparation of any volume within the consistency group fails, a “Withdraw-FlashCopy-revert” command may be executed, thereby causing a retention of the prior FlashCopy point-in-time copy. In the second phase, executed if all preparations are successful, a “Withdraw-FlashCopy-commit” command may be executed to remove all write-inhibit indicators, complete the creation of the new FlashCopy point-in-time copy and secure the new consistency group. Write requests to the FlashCopy source volumes may then be received and processed without risking corruption of the new consistency group on the Flashcopy target volumes.

    摘要翻译: 提供了一个两阶段FlashCopy操作,可用于帮助跨多个存储控制单元形成一致性组。 在第一阶段,创建新的一致性组的准备工作通过“建立-FromCopy-revertible”命令写入禁止源卷“可回复”。 如果一致性组中的任何卷的准备失败,则可以执行“Withdraw-FlashCopy-revert”命令,从而保留先前的FlashCopy时间点副本。 在第二阶段,如果所有准备工作都成功执行,则可以执行“Withdraw-FlashCopy-commit”命令来删除所有禁止写入指示符,完成创建新的FlashCopy时间点副本并确保新的一致性 组。 然后可以接收并处理向FlashCopy源卷写入请求,而不会在Flashcopy目标卷上新的一致性组的损坏风险。

    Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample
    3.
    发明授权
    Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample 有权
    定量RT-PCR到AC133以诊断癌症并监测细胞样品中的血管生成活性

    公开(公告)号:US07252976B2

    公开(公告)日:2007-08-07

    申请号:US10618102

    申请日:2003-07-11

    IPC分类号: C12P19/34 C12Q1/68 C07H21/04

    摘要: The present invention involves the use of quantitative RT-PCR to identify AC133 as a marker. AC133 is prevalent on endothelial progenitor cells (EPCs), which are important cells in angiogenesis. Therefore, the invention is applied to ascertain the quantity of EPCs in a subject, and to diagnose and monitor angiogenesis, for example, in injured tissues and in cancer development and progression.

    摘要翻译: 本发明涉及使用定量RT-PCR鉴定AC133作为标记物。 AC133在内皮祖细胞(EPCs)中是普遍存在的,其是血管发生中的重要细胞。 因此,本发明应用于确定受试者中EPCs的数量,并用于诊断和监测血管发生,例如在损伤组织和癌症发展和进展中。

    Updating elements in data storage facility using predefined state machine over extended time period
    4.
    发明授权
    Updating elements in data storage facility using predefined state machine over extended time period 有权
    使用预定义的状态机在更长的时间内更新数据存储设备中的元素

    公开(公告)号:US08881134B2

    公开(公告)日:2014-11-04

    申请号:US12769763

    申请日:2010-04-29

    IPC分类号: G06F9/445

    CPC分类号: G06F8/65

    摘要: A sequence for distributing at least one of a plurality of code packages to the at least one facility according to different states of a fixed state machine is set. The at least one of the plurality of code packages is installed in at least one staging area. The at least one of the plurality of code packages is maintained in the at least one staging area in a valid, dormant mode while the fixed state machine is stopped. Pursuant to a resumption of the fixed state machine at a subsequent time, a current code package is swapped with the at least one of the plurality of code packages in the at least one staging area to activate the at least one of the plurality of code packages.

    摘要翻译: 设置用于根据固定状态机的不同状态向至少一个设施分发多个代码包中的至少一个的序列。 所述多个代码包中的至少一个被安装在至少一个分段区域中。 在固定状态机停止时,多个代码包中的至少一个被保持在有效的休眠模式的至少一个暂存区域中。 根据随后的时间恢复固定状态机,当前代码包与至少一个暂存区域中的多个代码包中的至少一个交换,以激活多个代码包中的至少一个代码包 。

    Updating elements in data storage facility using predefined state machine over extended time period
    5.
    发明授权
    Updating elements in data storage facility using predefined state machine over extended time period 有权
    使用预定义的状态机在更长的时间内更新数据存储设备中的元素

    公开(公告)号:US08959505B2

    公开(公告)日:2015-02-17

    申请号:US13464098

    申请日:2012-05-04

    IPC分类号: G06F9/445

    CPC分类号: G06F8/65

    摘要: A sequence for distributing at least one of a plurality of code packages to the at least one facility according to different states of a fixed state machine is set. The at least one of the plurality of code packages is installed in at least one staging area. The at least one of the plurality of code packages is maintained in the at least one staging area in a valid, dormant mode while the fixed state machine is stopped. Pursuant to a resumption of the fixed state machine at a subsequent time, a current code package is swapped with the at least one of the plurality of code packages in the at least one staging area to activate the at least one of the plurality of code packages.

    摘要翻译: 设置用于根据固定状态机的不同状态向至少一个设施分发多个代码包中的至少一个的序列。 所述多个代码包中的至少一个被安装在至少一个分段区域中。 在固定状态机停止时,多个代码包中的至少一个被保持在有效的休眠模式的至少一个暂存区域中。 根据随后的时间恢复固定状态机,当前代码包与至少一个暂存区域中的多个代码包中的至少一个交换,以激活多个代码包中的至少一个代码包 。

    Unattended code update of storage facility
    6.
    发明授权
    Unattended code update of storage facility 失效
    存储设施的无人值守代码更新

    公开(公告)号:US08397061B2

    公开(公告)日:2013-03-12

    申请号:US12769790

    申请日:2010-04-29

    IPC分类号: H04L9/00

    CPC分类号: H04L9/3263 G06F21/572

    摘要: Various embodiments for providing an update to at least one storage facility in a computing storage environment are provided. In one embodiment, a security verification is performed on the update via a certificate authentication mechanism to confirm a validity of the update. Subsequent to confirming the validity of the update, a safety verification on the update is performed to confirm a suitability of the update to the at least one storage facility. If the security and safety verifications are validated, the update is provided and installed in the at least one storage facility.

    摘要翻译: 提供了用于向计算存储环境中的至少一个存储设施提供更新的各种实施例。 在一个实施例中,通过证书认证机制对更新执行安全验证,以确认更新的有效性。 在确认更新的有效性之后,执行更新的安全验证,以确认对至少一个存储设施的更新的适用性。 如果安全和安全验证被验证,则提供更新并将其安装在至少一个存储设施中。

    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer
    7.
    发明授权
    Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer 有权
    氟胞苷衍生物和COX-2抑制剂用于治疗癌症

    公开(公告)号:US08044033B2

    公开(公告)日:2011-10-25

    申请号:US12281160

    申请日:2007-03-02

    申请人: Edward H. Lin

    发明人: Edward H. Lin

    IPC分类号: A01N43/04 A61K31/70

    摘要: The present invention provides, in certain embodiments, methods for the treatment of colorectal cancer comprising administering a COX-2 inhibitor and fluorocytidine derivative to a human patient. In certain embodiments, a radiation therapy is also administered to the patient.

    摘要翻译: 在某些实施方案中,本发明提供了用于治疗结肠直肠癌的方法,包括向人患者施用COX-2抑制剂和氟胞嘧啶衍生物。 在某些实施方案中,也向患者施用放射治疗。

    FLUOROCYTIDINE DERIVATIVES AND COX-2 INHIBITORS FOR THE TREATMENT OF CANCER
    8.
    发明申请
    FLUOROCYTIDINE DERIVATIVES AND COX-2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
    荧光素衍生物和COX-2抑制剂治疗癌症

    公开(公告)号:US20090156548A1

    公开(公告)日:2009-06-18

    申请号:US12281160

    申请日:2007-03-02

    申请人: Edward H. Lin

    发明人: Edward H. Lin

    摘要: The present invention provides, in certain embodiments, methods for the treatment of colorectal cancer comprising administering a COX-2 inhibitor and fluorocytidine derivative to a human patient. In certain embodiments, a radiation therapy is also administered to the patient.

    摘要翻译: 在某些实施方案中,本发明提供了用于治疗结肠直肠癌的方法,包括向人患者施用COX-2抑制剂和氟胞嘧啶衍生物。 在某些实施方案中,也向患者施用放射治疗。